Voglitor R 1/0.2 Tablet Substitute

Substitutes of Voglitor R 1/0.2 Tablet meet the same safety and efficacy standards as Voglitor R 1/0.2 Tablet , but small differences in absorption or formulation can exist. A doctor can help you choose the right one for your needs.

Yes. Substitutes of Voglitor R 1/0.2 Tablet may vary in color, size, or shape due to differences in manufacturing and branding, but this does not affect how they work.

Yes, it’s generally safe to switch between multiple substitutes of Voglitor R 1/0.2 Tablet if they have the same salt and strength. However, always inform your doctor so they can monitor how your body responds.

Yes, many people safely use substitutes of Voglitor R 1/0.2 Tablet for long-term treatment. Just ensure it’s done under medical supervision.

If your symptoms stay under control or lab results remain stable, the substitute for Voglitor R 1/0.2 Tablet is likely working well. Regular follow-ups with your doctor are important.

Absolutely. Even with the same salt, small differences can affect how your body responds when switching from Voglitor R 1/0.2 Tablet to its substitute. Always consult your doctor before switching.

Voglitor R 1/0.2 Tablet is primarily used to treat Type 2 diabetes. It prevents the rise of blood sugar levels after a meal.

Voglitor R 1/0.2 Tablet is composed of two medicines, namely Repaglinide and voglibose. Repaglinide increases the amount of insulin released by the pancreas by stimulating the pancreas to release insulin into the body and helps regulate the amount of glucose (sugar) in the blood. Voglibose helps control the amount of glucose (sugars) in the blood by inhibiting the intestinal enzyme (alpha-glucosidase) and delaying the digestion and absorption of carbohydrates in the intestine. Altogether, they prevent blood sugar from rising very high after meals.

If you have symptoms like increased hunger, thirst, frequent urination (usually at night), unexplained weight loss, fatigue, blurred vision, slow wound/sores healing, and frequent infections, contact the doctor, as it can be a condition of type 2 diabetes.

No. Voglitor R 1/0.2 Tablet is only prescribed to treat type 2 diabetes, also called 'non-insulin-dependent diabetes.

Voglitor R 1/0.2 Tablet should be avoided in patients allergic to any of the components or excipients of this medicine. It should be avoided in patients with moderate to severe kidney or liver disease. Using this drug is also not advised if you drink too much alcohol. Make sure to inform your healthcare professional if you are pregnant or breastfeeding.

Do not take Voglitor R 1/0.2 Tablet if you are pregnant unless prescribed by the doctor. Your doctor will prescribe Voglitor R 1/0.2 Tablet only if the benefits outweigh the risks.

Please do not stop taking Voglitor R 1/0.2 Tablet without consulting your doctor on your own, as it may cause an increase in blood glucose levels. Continue taking Voglitor R 1/0.2 Tablet for as long as your doctor prescribes it. Do not be reluctant to speak with your doctor if you experience any difficulty while taking Voglitor R 1/0.2 Tablet .

Swallow the medicine as a whole with water; do not crush, break or chew it.

Voglitor R 1/0.2 Tablet is composed of two medicines, namely Repaglinide and voglibose.

The dose of Voglitor R 1/0.2 Tablet depends on your medical condition, age, and response to treatment. Your doctor will determine the best dose for you.

Common side effects of Voglitor R 1/0.2 Tablet may include hypoglycaemia, allergy, stomach pain, diarrhoea, and nausea. These side effects may occur in some individuals but not everyone. Most side effects are temporary and don't require medical attention, but consult your doctor if they persist.

Before starting Voglitor R 1/0.2 Tablet , discuss your medical history, allergies, current medications, and concerns with your physician.

Take the missed dose as soon as you remember unless it's almost time for your next dose. In this case, skip the missed dose and take your next dose at the regular time. Never take a double dose to make up for a missed one.